SCHEMBL5144810

SCHEMBL5144810

CCOCc1nc2c(N)nc3cc(Br)ccc3c2s1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 18/20 0.50
TLR8 Q9NR97 17/20 0.50
DHFR P00374 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5144738 0.84 TLR8 (0.68) TLR7TLR8
SCHEMBL1528088 0.83 TLR8 (0.73) TLR7TLR8
SCHEMBL2809369 0.82 TLR8 (0.44) TLR7TLR8
SCHEMBL5146603 0.81 TLR8 (0.49) TLR7TLR8
SCHEMBL5146563 0.81 TLR8 (0.51) TLR7TLR8DHFR
SCHEMBL5146721 0.79 NOS3 (0.47) TLR7TLR8
SCHEMBL5146450 0.78 MEN1 (0.35) TLR7TLR8DHFR
SCHEMBL23421958 0.76 TLR7 (0.41) TLR7TLR8
SCHEMBL23422311 0.76 TLR8 (0.44) TLR7TLR8
SCHEMBL23422069 0.74 TLR8 (0.42) TLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY 2007-11-08 US disclosed
WO-2006093514-A2 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259907-A1 ARYL AND ARYLALKYLENYL SUBSTITUTED THIAZOLOQUINOLINES AND THIAZOLONAPHTHYRIDINES IL2, TSLP, IFNG TLR7 39/4885TLR8 86/4885DHFR 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.